Table 8.
Fatty Acid Indices | CONC | PALM | SOYA | BEET | P-Value |
---|---|---|---|---|---|
SFA | 76.85 ± 0.42 | 78.21 ± 0.5 | 77.36 ± 0.14 | 77.91 ± 0.4 | 0.03 |
UFA | 23.15 ± 0.42 | 21.79 ± 0.5 | 22.64 ± 0.14 | 22.09 ± 0.4 | 0.03 |
PUFA | 3.03 ± 0.01 | 2.47 ± 0.03 | 3.18 ± 0.15 | 3.15 ± 0.03 | <0.001 |
MUFA | 20.12 ± 0.43 | 19.33 ± 0.52 | 19.46 ± 0.06 | 18.94 ± 0.38 | 0.08 |
PUFA/SFA | 0.04 ± 0.01 | 0.03 ± 0.01 | 0.04 ± 0.01 | 0.04 ± 0.01 | <0.001 |
MUFA/SFA | 0.26 ± 0.01 | 0.25 ± 0.01 | 0.25 ± 0 | 0.24 ± 0.01 | 0.07 |
Hardness Index (C18:1n–9 cis/C16:) | 0.46 ± 0.03 | 0.46 ± 0.03 | 0.44 ± 0.01 | 0.39 ± 0.01 | 0.07 |
Short Chain (C4–C14) | 30.11 ± 0.26 | 34.21 ± 0.49 | 30.6 ± 0.29 | 30.82 ± 0.08 | <0.001 |
Medium Chain (C15–C17) | 40.25 ± 1.58 | 38.49 ± 1.31 | 40.62 ± 0.54 | 42.95 ± 0.35 | 0.02 |
Long Chain (C18–C24) | 29.64 ± 1.39 | 27.3 ± 0.85 | 28.77 ± 0.62 | 26.23 ± 0.34 | 0.02 |
Ω-3 | 0.69 ± 0.03 | 0.46 ± 0.03 | 0.66 ± 0.03 | 0.64 ± 0.04 | 0.00 |
Ω-6 | 1.14 ± 0.03 | 0.94 ± 0.03 | 1.36 ± 0.16 | 1.27 ± 0.02 | 0.01 |
Ω-9 | 17.14 ± 0.65 | 16.14 ± 0.56 | 16.45 ± 0.19 | 15.51 ± 0.29 | 0.04 |
Ω-3/Ω-6 | 0.6 ± 0.03 | 0.49 ± 0.04 | 0.5 ± 0.07 | 0.5 ± 0.03 | 0.14 |
AI | 4.18 ± 0.13 | 4.79 ± 0.15 | 4.35 ± 0.07 | 4.6 ± 0.10 | <0.001 |
TI | 4.4 ± 0.10 | 4.81 ± 0.19 | 4.56 ± 0.04 | 4.75 ± 0.17 | 0.07 |
C14:/C14:0 | 0.1 ± 0.01 | 0.1 ± 0.01 | 0.09 ± 0.01 | 0.11 ± 0.01 | 0.18 |
C16:1/C16:0 | 0.05 ± 0.01 | 0.05 ± 0.01 | 0.05 ± 0.01 | 0.05 ± 0.01 | 0.16 |
Σ18:1/C18:0 | 1.86 ± 0.08 | 1.9 ± 0.04 | 1.84 ± 0.05 | 2.11 ± 0.12 | 0.04 |
LA/ALA | 1.51 ± 0.07 | 1.89 ± 0.18 | 1.93 ± 0.34 | 1.85 ± 0.13 | 0.24 |
De novo (C4–C14) | 28.87 ± 0.29 | 32.82 ± 0.52 | 29.40 ± 0.28 | 29.42 ± 0.06 | <0.001 |
SFA: saturated fatty acids; UFA: unsaturated fatty acids; PUFA: poly unsaturated fatty acids; MUFA: mono-unsaturated fatty acids; TI: thrombogenic; AI: atherogenic; LA: linoleic acid.